<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2176-6223</journal-id>
<journal-title><![CDATA[Revista Pan-Amazônica de Saúde]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Pan-Amaz Saude]]></abbrev-journal-title>
<issn>2176-6223</issn>
<publisher>
<publisher-name><![CDATA[Instituto Evandro Chagas. Secretaria de Vigilância em Saúde e Ambiente. Ministério da Saúde]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2176-62232020000100019</article-id>
<article-id pub-id-type="doi">10.5123/s2176-6223202000378</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Estudo soroepidemiológico do sarampo em populações residentes na Região Metropolitana de Belém, estado do Pará, Brasil, 2016 a 2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Seroepidemiological study of measles in populations living in the metropolitan region of Belém, Pará State, Brazil, 2016 to 2018]]></article-title>
<article-title xml:lang="es"><![CDATA[Estudio seroepidemiológico del sarampión en poblaciones residentes en la Región Metropolitana de Belém, estado de Pará, Brasil, 2016 a 2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moraes]]></surname>
<given-names><![CDATA[Marluce Matos de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sagica]]></surname>
<given-names><![CDATA[Fernanda do Espírito Santo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jesus]]></surname>
<given-names><![CDATA[Maria Izabel de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medeiros]]></surname>
<given-names><![CDATA[Renato Lopes Fernandes de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Dorotea de Fátima Lobato da]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[Haroldo José de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nunes]]></surname>
<given-names><![CDATA[Heloisa Marceliano]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[Sueli Guerreiro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Evandro Chagas/SVS/MS  ]]></institution>
<addr-line><![CDATA[Ananindeua Pará]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>11</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_arttext&amp;pid=S2176-62232020000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_abstract&amp;pid=S2176-62232020000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_pdf&amp;pid=S2176-62232020000100019&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  OBJETIVO: Investigar a soroprevalência de anticorpos contra o sarampo em adultos jovens, residentes em Belém e Ananindeua, estado do Pará, Brasil, visando identificar indivíduos suscetíveis.  MATERIAIS E MÉTODOS: Estudo transversal, por conglomerado, de 2.220 indivíduos, sendo 1.109 de Belém e 1.111 de Ananindeua, da faixa etária de 15-39 anos, procedentes de escolas, faculdades, universidades, instituto de pesquisa e quartéis. Dados dos participantes foram coletados mediante questionário epidemiológico e digitados utilizando o software Epi-Info&#8482; v7.0. O teste binomial foi utilizado para a análise de duas proporções por meio do programa BioEstat v5.3, nível de significância p &lt; 0,05.  RESULTADOS: A suscetibilidade geral para o sarampo foi de 17,2%, sendo 16,4% em Belém e 18,0% em Ananindeua, maior no sexo masculino, com ampla distribuição geográfica. Foi significativa a diferença na soropositividade em relação aos tipos de vacina recebida, tendo a vacina tríplice viral (SCR) os maiores percentuais, assim como a comparação das informações entre autorreferidos e comprovados por vacinação. Quanto ao número de doses, não houve significância na soropositividade entre os que referiram uma dose em relação a três doses da vacina contra o sarampo. Foi detectado um declínio dos níveis de anticorpos ao longo do tempo (20 anos) após a última vacinação.  CONCLUSÃO: Existem grupos de suscetíveis formando bolsões de vulneráveis em ambos os munícipios, assinalando a necessidade do fortalecimento da vigilância epidemiológica e de estratégias de vacinação, diante da reintrodução do vírus, para o controle da doença no Brasil.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  OBJECTIVE: To investigate the seroprevalence of antibodies against measles in young adults living in Belém and Ananindeua, Pará State, Brazil, in order to identify susceptible individuals.  MATERIALS AND METHODS: Cross-sectional study by conglomerate, from 2,220 individuals (1,109 from Belém and 1,111 from Ananindeua), aged between 15 to 39 years old, being volunteers from schools, colleges, universities, research institutes, and barracks. Data were collected through an epidemiological questionnaire and entered using Epi-Info&#8482; v7.0. The binomial test was used to analyze two proportions using BioEstat v5.3, significance level p &lt; 0.05.  RESULTS: The general susceptibility to measles was 17.2%, with 16.4% in Belém and 18.0% in Ananindeua, which was higher in males, with a wide geographical distribution. There was a significant difference in seropositivity in relation to the types of vaccine administered, with the triple viral vaccine (measles, mumps, rubella) reaching the highest percentages, as well as the comparison of information between self-reported and proven ones. Number of doses did not show significance in soropositivity when comparing individuals who referred one dose and the ones reporting three doses of measles vaccine. A decline in antibody levels over time (20 years) after the last vaccination was detected.  CONCLUSION: There are groups of susceptible people forming pockets of vulnerable people in both municipalities, highlighting the need to strengthen epidemiological surveillance and vaccination strategies, in view of the reintroduction of the virus, in order to control the disease in Brazil.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  OBJETIVO: Investigar la seroprevalencia de anticuerpos contra el sarampión en adultos jóvenes, residentes en Belém y Ananindeua, estado de Pará, Brasil, con el objetivo de identificar individuos susceptibles.  MATERIALES Y MÉTODOS: Se trata de un estudio transversal de 2.220 personas, 1.109 de Belém y 1.111 de Ananindeua, entre 15 y 39 años, de escuelas, colegios, universidades, institutos de investigación y cuarteles. Los datos de los participantes se recogieron a través de un cuestionario epidemiológico y se tipificaron utilizando el software Epi info&#8482; v7.0. Se utilizó la prueba binomial para el análisis de dos proporciones a través del programa BioEstat v5.3, nivel de significación p &lt; 0,05.  RESULTADOS: La susceptibilidad general al sarampión fue del 17,2%, 16,4% en Belém y 18,0% en Ananindeua, más en el sexo masculino, con amplia distribución geográfica. La diferencia en la seropositividad en relación a los tipos de vacuna recibida fue significativa, los porcentajes más altos fueron de la vacuna triple viral (SRP), así como la comparación de la información entre autoinformada y comprobada por vacunación. Con respecto al número de dosis, no hubo significación en la seropositividad entre los que informaron una dosis en relación a tres dosis de la vacuna contra el sarampión. Se detectó una disminución en los niveles de anticuerpos con el tiempo (20 años) después de la última vacunación.  CONCLUSIÓN: Hay grupos de susceptibles que forman focos de personas vulnerables en ambos municipios, lo que indica la necesidad de fortalecer la vigilancia epidemiológica y las estrategias de vacunación, en vista de la reintroducción del virus, para controlar la enfermedad en Brasil.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Sarampo]]></kwd>
<kwd lng="pt"><![CDATA[Vacina]]></kwd>
<kwd lng="pt"><![CDATA[Erradicação de Doenças]]></kwd>
<kwd lng="pt"><![CDATA[Estudos Soroepidemiológicos]]></kwd>
<kwd lng="en"><![CDATA[Measles]]></kwd>
<kwd lng="en"><![CDATA[Vaccine]]></kwd>
<kwd lng="en"><![CDATA[Disease Eradication]]></kwd>
<kwd lng="en"><![CDATA[Seroepidemiological Studies]]></kwd>
<kwd lng="es"><![CDATA[Sarampión]]></kwd>
<kwd lng="es"><![CDATA[Vacuna]]></kwd>
<kwd lng="es"><![CDATA[Erradicación de Enfermedades]]></kwd>
<kwd lng="es"><![CDATA[Estudios Seroepidemiológicos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laksono]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Vries]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[McQuaid]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Duprex]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Swart]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measles virus host invasion and pathogenesis]]></article-title>
<source><![CDATA[Viruses]]></source>
<year>2016</year>
<volume>8</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>210</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviços</collab>
<source><![CDATA[Guia de vigilância em saúde]]></source>
<year>2017</year>
<volume>Vol. 1</volume>
<page-range>119-34</page-range><publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prevots]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Parise]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Segatto]]></surname>
<given-names><![CDATA[TCV]]></given-names>
</name>
<name>
<surname><![CDATA[Siqueira]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[Ganter]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interruption of measles transmission in Brazil, 2000-2001]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>2003</year>
<volume>187</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>S111-20</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR)</collab>
<source><![CDATA[Calendário nacional de vacinação [Internet]]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mello]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Haddad]]></surname>
<given-names><![CDATA[DAR]]></given-names>
</name>
<name>
<surname><![CDATA[Câmara]]></surname>
<given-names><![CDATA[GNP]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Abrahão]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Procaci]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Panorama atual do sarampo no mundo: risco de surtos nos grandes eventos no Brasil]]></article-title>
<source><![CDATA[J Bras Med]]></source>
<year>2014</year>
<volume>102</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-40</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jesus]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigação de surto de sarampo no Estado do Pará na era da eliminação da doença no Brasil]]></article-title>
<source><![CDATA[Cad Saude Publica]]></source>
<year>2015</year>
<volume>31</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2241-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis</collab>
<source><![CDATA[Plano de contingência para resposta às emergências de saúde pública: sarampo]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Pan American Health Organization, World Health Organization</collab>
<source><![CDATA[Region of the Americas is declared free or measles [Internet]]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[PAHO, WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[New measles surveillance data from WHO [Internet]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>Centers for Disease Control and Prevention</collab>
<article-title xml:lang=""><![CDATA[Nationwide rubella epidemic - Japan, 2013]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep]]></source>
<year>2013</year>
<volume>62</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>457-86</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Measles and rubella surveillance data. Reported measles and rubella cases and incidence rates by member states [Internet]]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde</collab>
<article-title xml:lang=""><![CDATA[Situação do sarampo no Brasil - 2018]]></article-title>
<source><![CDATA[Informe]]></source>
<year>2018</year>
<numero>32</numero>
<issue>32</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde</collab>
<article-title xml:lang=""><![CDATA[Situação do sarampo no Brasil - 2018-2019]]></article-title>
<source><![CDATA[Informe]]></source>
<year>2019</year>
<numero>37</numero>
<issue>37</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde</collab>
<article-title xml:lang=""><![CDATA[Vigilância epidemiológica do sarampo no Brasil 2019: janeiro a dezembro]]></article-title>
<source><![CDATA[Bol Epidemiol]]></source>
<year>2020</year>
<volume>51</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pacheco]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[França]]></surname>
<given-names><![CDATA[GVA]]></given-names>
</name>
<name>
<surname><![CDATA[Elidio]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Guilhem]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measles-containing vaccines in Brazil: coverage, homogeneity of coverage and associations with contextual factors at municipal level]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2020</year>
<volume>38</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1881-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Departamento de Informática do SUS</collab>
<source><![CDATA[Imunizações - cobertura - Pará [Internet]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Word Health Organization</collab>
<source><![CDATA[Measles - global situation [Internet]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fraser-bell]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global re-emergence of measles - 2019 update]]></article-title>
<source><![CDATA[Glob Biosecur]]></source>
<year>2019</year>
<volume>1</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>Prefeitura Municipal de Belém (PA)</collab>
<source><![CDATA[Anuário estatístico do município de Belém 2011]]></source>
<year>2012</year>
<edition>16. ed</edition>
<publisher-loc><![CDATA[Secretaria Municipal de Coordenação Geral do Planejamento e Gestão ]]></publisher-loc>
<publisher-name><![CDATA[Belém]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gusmão]]></surname>
<given-names><![CDATA[LHA]]></given-names>
</name>
</person-group>
<source><![CDATA[Mapas dos bairros de Ananindeua (serviço) [Internet]]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<collab>Brasil. Ministério da Saúde. Comissão Nacional de Ética em Pesquisa</collab>
<article-title xml:lang=""><![CDATA[Resolução nº 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos [Internet]]]></article-title>
<source><![CDATA[[Diário Oficial da União]]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estofolete]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Milhim]]></surname>
<given-names><![CDATA[BHGA]]></given-names>
</name>
<name>
<surname><![CDATA[França]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[GCD]]></given-names>
</name>
<name>
<surname><![CDATA[Augusto]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Terzian]]></surname>
<given-names><![CDATA[ACB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of measles antibodies in São José do Rio Preto, São Paulo, Brazil: a serological survey model]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2020</year>
<volume>10</volume>
<page-range>5179</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sampaio]]></surname>
<given-names><![CDATA[BCF]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Meireles]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade Jr]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo city, Brazil]]></article-title>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2020</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>51-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sato]]></surname>
<given-names><![CDATA[APS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil?]]></article-title>
<source><![CDATA[Rev Saude Publica]]></source>
<year>2018</year>
<volume>52</volume>
<page-range>96</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poethko-Müller]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mankertz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2012</year>
<volume>7</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moraes]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[ACR]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[DFL]]></given-names>
</name>
<name>
<surname><![CDATA[Sagica]]></surname>
<given-names><![CDATA[FES]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[ECO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trajetória da rubéola no Estado do Pará, Brasil: rumo à erradicação]]></article-title>
<source><![CDATA[Rev Pan-Amaz Saude]]></source>
<year>2015</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-28</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tafuri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gallone]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Gallone]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Pappagallo]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Larocca]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Germinario]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitoring the process of measles elimination by serosurveillance data: the apulian 2012 study]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2016</year>
<volume>34</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>2092-5</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Noronha]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Siqueira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pavão]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudo comparativo da imunogenicidade da vacina tríplice viral (sarampo, caxumba e rubéola) nas apresentações monodose e multidose, em lactentes]]></source>
<year>2018</year>
<conf-name><![CDATA[ 6ºSeminário Anual Científico e Tecnológico de Bio-Manguinhos]]></conf-name>
<conf-date>2018</conf-date>
<conf-loc>Rio de Janeiro, RJ </conf-loc>
<page-range>24-5</page-range><publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Bio-Manguinhos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivière]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tretiak]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Levinton]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fitzsimon]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leclerc]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada]]></article-title>
<source><![CDATA[Can J Infect Dis]]></source>
<year>1997</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>257-64</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis</collab>
<source><![CDATA[Manual de normas e procedimentos para vacinação]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An increasing, potentially measles-susceptible population over time after vaccination in Korea]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2017</year>
<volume>35</volume>
<numero>33</numero>
<issue>33</issue>
<page-range>4126-32</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<collab>Centers for Disease Control and Prevention</collab>
<source><![CDATA[Plan for travel [Internet]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Atlanta (GA) ]]></publisher-loc>
<publisher-name><![CDATA[Centers for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ogawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ae]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sasahara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship between self-reported vaccination history and measles and rubella antibody titers in medical and nursing students]]></article-title>
<source><![CDATA[Adv Infect Dis]]></source>
<year>2017</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>27-36</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lievano]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Helfand]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Harpaz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Walls]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lack of evidence of measles virus shedding in people with inapparent measles virus infections]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>2004</year>
<volume>189</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>S165-70</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smetana]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chlibek]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hanovcova]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sosovickova]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Smetanova]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decreasing seroprevalence of measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2017</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wiedermann]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Garner-Spitzer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary vaccine failure to routine vaccines: why and what to do?]]></article-title>
<source><![CDATA[Hum Vaccin Immunother]]></source>
<year>2016</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>239-43</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Secretaria de Atenção à Saúde</collab>
<source><![CDATA[Relatório da verificação dos critérios de eliminação da transmissão dos vírus endêmicos do sarampo e rubéola e da síndrome da rubéola congênita (SRC) no Brasil]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
